Shanghai Bao Pharmaceuticals Co Ltd

02659

Company Profile

  • Business description

    Shanghai Bao Pharmaceuticals Co Ltd is a biotechnology company with an approved product and a diverse clinical pipeline, leveraging synthetic biology technology to develop and deliver recombinant biologic drugs in China, targeting conditions with limited treatment options and complex manufacturing challenges. The company has proprietary technology platforms, supported by its chassis cell engineering technology, that combine drug design and bioprocessing capabilities. It has production lines for finished dosage forms, including injectable solutions, lyophilized powder injections, and pre-filled syringes. The group has only one reportable operating segment, which is the research, development, and commercialisation of pharmaceutical products.

  • Contact

    No. 28 Luoxin Road
    Baoshan District
    Shanghai
    CHN

    T: +86 2156696602

    https://www.baopharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    354

Stocks News & Analysis

stocks

Investors overlooking ASX share’s potential

International expansion is a distraction from valuable local business.
stocks

Cerebras sees blockbuster demand, setting stage for US AI IPO frenzy

The chipmaker’s IPO priced at $185, well above its initial range, and opened trading at an eye-popping $350.
stocks

What did Morningstar subscribers buy and sell in April?

How the most traded shares in April stack up against our analysts views.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,870.6046.70-0.52%
CAC 407,952.55129.72-1.61%
DAX 4023,950.57505.69-2.07%
Dow JONES (US)49,526.17537.29-1.07%
FTSE 10010,195.37177.56-1.71%
HKSE25,962.73426.31-1.62%
NASDAQ26,225.14410.08-1.54%
Nikkei 22561,409.291,244.76-1.99%
NZX 50 Index12,965.0160.06-0.46%
S&P 5007,408.5092.74-1.24%
S&P/ASX 2008,630.8042.70-0.49%
SSE Composite Index4,135.3942.53-1.02%

Market Movers